[FG] Bernsmeier Christine

Schaeffer, S. et al. (2024) ‘Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease’, Frontiers in Network Physiology, 4. Available at: https://doi.org/10.3389/fnetp.2024.1458665.

Woelfel, S. et al. (2024) ‘STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease’, Vaccines, 12(11), p. 1241. Available at: https://doi.org/10.3390/vaccines12111241.

Moschouri, Eleni et al. (2024) ‘Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis’, Swiss Medical Weekly, 154(6), p. 3698. Available at: https://doi.org/10.57187/s.3698.

Moschouri, E. et al. (2024) ‘Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis’, Swiss Medical Weekly, 154(6), p. 3698. Available at: https://doi.org/10.57187/s.3698.

Flint, E. et al. (2024) ‘Targeting the expansion of myeloid-derived suppressor cells in liver cirrhosis’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.03.29.587228.

Efe, Cumali et al. (2024) ‘Efficacy and Safety of Infliximab in Patients with Autoimmune Hepatitis’, Hepatology [Preprint]. Available at: https://doi.org/10.1097/HEP.0000000000001089.

Flint, E. et al. (2023) ‘Targeting myeloid-derived suppressor cells in a carbon tetrachloride-induced murine model of chronic liver injury’, Journal of Hepatology, 78, p. S214. Available at: https://doi.org/10.1016/s0168-8278(23)00758-4.

Patseas, D. et al. (2023) ‘Investigating the PD-1/PD-L pathway and macrophage responses in acute-on-chronic liver failure’, Journal of Hepatology, 78, pp. S84–S85. Available at: https://doi.org/10.1016/s0168-8278(23)00561-5.

Roth, S. et al. (2023) ‘Circadian sleep-wake rhythms in non-alcoholic fatty liver disease’, Journal of Hepatology, 78, pp. S754–S755. Available at: https://doi.org/10.1016/s0168-8278(23)02166-9.

Trovato FM et al. (2023) ‘Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure.’, Journal of hepatology, 78(3), pp. 558–573. Available at: https://doi.org/10.1016/j.jhep.2022.10.031.

Etienne S et al. (2023) ‘Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines.’, Journal of general internal medicine, 38(2), pp. 490–501. Available at: https://doi.org/10.1007/s11606-022-07806-9.

Brenig, R. and Bernsmeier, C. (2023) ‘Liver Cirrhosis’, Praxis, 112, pp. 554–561.

Bütikofer, Simon et al. (2023) ‘Determinants of Advanced Liver Fibrosis in Adult Patients After Fontan Palliation: Usefulness of Ultrasound Transient Elastography’, Canadian Journal of Cardiology, 39, pp. 1338–1345. Available at: https://doi.org/10.1016/j.cjca.2023.04.019.

Codoni, G. et al. (2023) ‘Histological and serological features of acute liver injury after SARS-CoV-2 vaccination’, JHEP Reports, 5(1). Available at: https://doi.org/10.1016/j.jhepr.2022.100605.

Ludz, C. et al. (2023) ‘Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study’, Swiss Medical Weekly, 153. Available at: https://doi.org/10.57187/smw.2023.40102.

Roth, Sofia et al. (2023) ‘Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure’, Gastro Hep Advances, 2, pp. 72–82. Available at: https://doi.org/10.1016/j.gastha.2022.08.006.

Schaeffer, Sofia et al. (2023) ‘Ribociclib-induced liver injury: a case report’, Frontiers in Oncology, 13. Available at: https://doi.org/10.3389/fonc.2023.1256783.

Uzun, Sarp et al. (2023) ‘Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics’, Journal of Hepatology, 79, pp. 666–676. Available at: https://doi.org/10.1016/j.jhep.2023.05.020.

Efe C et al. (2022) ‘Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.’, Hepatology (Baltimore, Md.), 76(6), pp. 1576–1586. Available at: https://doi.org/10.1002/hep.32572.

Guri Y et al. (2022) ‘Exacerbation of familial intrahepatic cholestasis in conjunction with COVID-19 vaccination.’, 77(3). Available at: https://doi.org/10.1016/j.jhep.2022.05.003.

Geng, A. et al. (2022) ‘Heterogeneity of peripheral blood monocytes in patients with cirrhosis’, Journal of Hepatology, 77, pp. S192–S193. Available at: https://doi.org/10.1016/s0168-8278(22)00759-0.

Khamri W et al. (2022) ‘Suppressor CD4(+) T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis.’, Gut, 71(6), pp. 1192–1202. Available at: https://doi.org/10.1136/gutjnl-2021-324071.

Flint, E., Triantafyllou, E. and Bernsmeier, C. (2022) ‘TAM Receptors in the Pathophysiology of Liver Disease’, Livers, 2, pp. 15–29. Available at: https://doi.org/10.3390/livers2010002.

Geng, Anne, Flint, Emilio and Bernsmeier, Christine (2022) ‘Plasticity of monocytes and macrophages in cirrhosis of the liver’, Frontiers in Network Physiology, 2. Available at: https://doi.org/10.3389/fnetp.2022.937739.

Sofia Roth et al. (2022) ‘Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure’, Gastro Hep Advances. 03.09.2022, 1(2), pp. 72–82. Available at: https://doi.org/10.1016/j.gastha.2022.08.006.

Van der Merwe S. et al. (2021) ‘The multifactorial mechanisms of bacterial infection in decompensated cirrhosis’, Journal of Hepatology, 75, pp. S82–S100. Available at: https://doi.org/10.1016/j.jhep.2020.11.029.

Triantafyllou E et al. (2021) ‘PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury.’, The Journal of clinical investigation, 131(4). Available at: https://doi.org/10.1172/jci140196.

Kronlage C et al. (2020) ‘Muscle stiffness, gait instability, and liver cirrhosis in Wilson’s disease.’, Lancet (London, England), 396(10256), p. 990. Available at: https://doi.org/10.1016/s0140-6736(20)31963-2.

Bernsmeier C and McPhail MJW (2020) ‘Editorial: outcome prediction in patients with cirrhosis and acute-on-chronic liver failure-authors” reply.’, 52(7). Available at: https://doi.org/10.1111/apt.16053.

Bernsmeier C et al. (2020) ‘Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.’, Alimentary pharmacology & therapeutics, 52(5), pp. 855–865. Available at: https://doi.org/10.1111/apt.15932.

Bernsmeier C, van der Merwe S and Périanin A (2020) ‘Innate immune cells in cirrhosis.’, Journal of hepatology, 73(1), pp. 186–201. Available at: https://doi.org/10.1016/j.jhep.2020.03.027.

Brenig R et al. (2020) ‘Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis.’, Life science alliance, 3(1). Available at: https://doi.org/10.26508/lsa.201900465.

Keerl C and Bernsmeier C (2020) ‘[Elevated liver function tests - as incidental finding in general practice].’, Therapeutische Umschau. Revue therapeutique, 77(8), pp. 371–378. Available at: https://doi.org/10.1024/0040-5930/a001206.

Ruperti-Repilado, Francisco Javier et al. (2019) ‘Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to; Artemisia annua; Tea’, Frontiers in medicine, 6, p. 221. Available at: https://doi.org/10.3389/fmed.2019.00221.

Mensing B et al. (2018) ‘[Wilson’s disease or hepatolenticular degeneration].’, Therapeutische Umschau. Revue therapeutique, 75(4), pp. 241–248. Available at: https://doi.org/10.1024/0040-5930/a000995.

Bernsmeier C et al. (2018) ‘CD14(+) CD15(-) HLA-DR(-) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.’, Gut. 07.06.2017, 67(6), pp. 1155–1167. Available at: https://doi.org/10.1136/gutjnl-2017-314184.

Triantafyllou E et al. (2018) ‘MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.’, Gut. 27.04.2017, 67(2), pp. 333–347. Available at: https://doi.org/10.1136/gutjnl-2016-313615.

Khamri W et al. (2017) ‘Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.’, Gastroenterology. 28.03.2017, 153(1), pp. 263–276.e8. Available at: https://doi.org/10.1053/j.gastro.2017.03.023.

Bernsmeier C and Albano E (2017) ‘Liver dendritic cells and NAFLD evolution: A remaining open issue.’, 66(6). Available at: https://doi.org/10.1016/j.jhep.2017.02.018.

Vergis N et al. (2017) ‘Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase.’, Gut. 09.02.2016, 66(3), pp. 519–529. Available at: https://doi.org/10.1136/gutjnl-2015-310378.

Bernsmeier, Christine et al. (2016) ‘Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation’, Laboratory Investigation, 96(9), pp. 972–80. Available at: https://doi.org/10.1038/labinvest.2016.75.

Khamri, W. et al. (2016) ‘CTLA-4 IS A NEGATIVE REGULATOR OF T CELL ACTIVATION IN ACUTE LIVER FAILURE’. ELSEVIER SCIENCE BV, 64.

Larsen FS et al. (2016) ‘High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.’, Journal of hepatology. 29.08.2015, 64(1), pp. 69–78. Available at: https://doi.org/10.1016/j.jhep.2015.08.018.

Manakkat Vijay GK et al. (2016) ‘Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure.’, Critical care medicine, 44(1), pp. 43–53. Available at: https://doi.org/10.1097/ccm.0000000000001309.

Mukherjee, S. K. et al. (2016) ‘MER TYROSINE KINASE POSITIVE TUMOUR ASSOCIATED MACROPHAGES ARE A NOVEL THERAPEUTIC TARGET IN HEPATOCELLULAR CARCINOMA’. ELSEVIER SCIENCE BV, 64.

Patel, V. C. et al. (2016) ‘ALTERED GUT MICROBIAL PROFILE IS A PROPONENTOF BACTERIAL TRANSLOCATION IN ACUTE- ON- CHRONIC LIVER FAILURE’. ELSEVIER SCIENCE BV, 64.

Singanayagam, A. et al. (2016) ‘MER TYROSINE KINASE REGULATES THE ACTIVATION OF MYELOID CELLS AND INNATE IMMUNE RESPONSES IN ACUTE-ON-CHRONIC LIVER FAILURE’. ELSEVIER SCIENCE BV, 64.

Triantafyllou, E. et al. (2016) ‘SECRETORY LEUKOCYTE PROTEASE INHIBITOR DRIVES HEPATIC RESOLUTION RESPONSES IN ACUTE LIVER FAILURE THROUGH MODULATION OF THE MER TYROSINE KINASE PATHWAY’. ELSEVIER SCIENCE BV, 64.

Bernsmeier, C. et al. (2015) ‘THERAPEUTIC PLASMA EXCHANGE MODULATES INNATE IMMUNE ACTIVATION AND IMPROVES OUTCOME IN PATIENTS WITH ACUTE LIVER FAILURE’. ELSEVIER SCIENCE BV, 62.

Bernsmeier, C. et al. (2015) ‘PROOF-OF-PRINCIPLE EVALUATION OF IMMUNOMODULATORY DRUGS IN PROMOTING PHAGOCYTOSIS CAPACITY IN PATIENTS WITH LIVER FAILURE’. ELSEVIER SCIENCE BV, 62.

McPhail, M. J. et al. (2015) ‘DIFFERENTIAL LEUKOCYTE COUNT AS AN ADJUNCTIVE BIOMARKER OF OUTCOME IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE’. ELSEVIER SCIENCE BV, 62.

Triantafyllou, E. et al. (2015) ‘SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) SUPPRESSES INNATE IMMUNE RESPONSES AND PROMOTES RESOLUTION OF INFLAMMATION IN AN AUTO/PARACRINE MANNER DURING ACUTE LIVER FAILURE (ALF)’. ELSEVIER SCIENCE BV, 62.

Bernsmeier C et al. (2015) ‘Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.’, Gastroenterology. 03.12.2014, 148(3), pp. 603–615.e14. Available at: https://doi.org/10.1053/j.gastro.2014.11.045.

Bernsmeier, Christine et al. (2015) ‘Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls’, PLoS ONE, 10(11), p. e0143293. Available at: https://doi.org/10.1371/journal.pone.0143293.

Bernsmeier C et al. (2015) ‘Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.’, Immunotherapy, 7(6), pp. 641–54. Available at: https://doi.org/10.2217/imt.15.27.

Bernsmeier C, Antoniades CG and Wendon J (2014) ‘What’s new in acute liver failure?’, Intensive care medicine. 01.07.2014, 40(10), pp. 1545–8. Available at: https://doi.org/10.1007/s00134-014-3350-4.

Bernsmeier, C. et al. (2014) ‘EARLY PLASMA EXCHANGE ALLEVIATES PRO-INFLAMMATORY CYTOKINE SECRETION OF PERIPHERAL MONOCYTES IN PATIENTS WITH ACUTE LIVER FAILURE’. SPRINGER, 40.

Antoniades CG et al. (2014) ‘Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.’, Hepatology (Baltimore, Md.). 28.02.2014, 59(4), pp. 1564–76. Available at: https://doi.org/10.1002/hep.26933.

Bernsmeier, C. et al. (2014) ‘MONOCYTE EXHAUSTION: A MECHANISTIC EXPLANATION FOR SUSCEPTIBILITY TO INFECTION IN LIVER FAILURE’. ELSEVIER SCIENCE BV, 60.

Bernsmeier, C. et al. (2014) ‘DAYTIME SLEEPINESS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IS LINKED TO INSULIN RESISTANCE, ELEVATED LIVER FUNCTION TESTS AND FIBROSIS’. ELSEVIER SCIENCE BV, 60.

Vergis, N. et al. (2014) ‘MONOCYTE OXIDATIVE BURST DEFECT PREDICTS RISK OF INFECTION IN ALCOHOLIC HEPATITIS’. ELSEVIER SCIENCE BV, 60.

Balmer, Maria L. et al. (2014) ‘The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota’, Science Translational Medicine, 6(237), p. 237ra66. Available at: https://doi.org/10.1126/scitranslmed.3008618.

Bernsmeier, Christine et al. (2014) ‘Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1’, Journal of Viral Hepatitis, 21(1), pp. 9–18. Available at: https://doi.org/10.1111/jvh.12208.

Bernsmeier, Christine et al. (2014) ‘Inhibition of MER receptor tyrosine kinase in patients with acute on chronic liver failure: a potential target for immunotherapy?’, HEPATOLOGY. WOS.ISTP, 60, pp. 489A–489A.

Bernsmeier C et al. (2014) ‘Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.’, PloS one. 29.01.2014, 9(1), p. e87488. Available at: https://doi.org/10.1371/journal.pone.0087488.

Patel, Vishal C. et al. (2014) ‘Bacterial translocation in liver failure: a possible mechanism of impaired innate immune responses and immuneparesis?’, HEPATOLOGY. WOS.ISTP, 60, pp. 493A–493A.

Triantafyllou, Evangelos et al. (2014) ‘Secretory Leukocyte Protease Inhibitor (SLPI) promotes hepatic resolution responses in acute liver failure (ALF)’. WILEY-BLACKWELL, 60.

Vijay, Godhev K. Manakkat et al. (2014) ‘Increased neutrophil actin production and translocation of myeloperoxidase in patients with acetaminophen-induced acute liver failure may contribute to multiorgan failure’. WILEY-BLACKWELL, 60.

Huber X et al. (2013) ‘When a colonoscopy becomes a duodenoscopy: a palliative treatment of a malignant sigmoidoduodenal fistula.’, BMJ case reports, 2013. Available at: https://doi.org/10.1136/bcr-2012-008241.

Bernsmeier, C. et al. (2013) ‘GLUCOSE-INDUCED GLUCAGON-LIKE PEPTIDE 1 SECRETION IS DEFICIENT IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE’. ELSEVIER SCIENCE BV, 58.

Bernsmeier, C. et al. (2012) ‘NOTCH1 DELETION IN HEPATOCYTES PREDISPOSES TO DIABETES AND LIVER STEATOSIS THROUGH DYSREGULATION OF GENES INVOLVED IN GLUCOSE AND LIPID HOMEOSTASIS’. ELSEVIER SCIENCE BV, 56.

Rosin C et al. (2012) ‘Daptomycin for highly resistant Enterococcus faecium infection.’, Swiss medical weekly. 26.06.2012, 142, p. w13603. Available at: https://doi.org/10.4414/smw.2012.13603.

Bernsmeier,C and Heim,MH (2011) ‘Non-alcoholic fatty liver disease and steatohepatitis: Hepatic manifestations of the metabolic syndrome’, 11(5), pp. 53–57.

Bernsmeier C. et al. (2010) ‘Urinary tract infection presenting with nonspecific complaints and normal urinalysis in 84-year-old woman’, American Journal of Case Reports, 11, pp. 116–118.

Filipowicz, Magdalena et al. (2010) ‘S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse’, PLoS ONE, 5(11), p. e15492. Available at: https://doi.org/10.1371/journal.pone.0015492.

Osthoff M et al. (2010) ‘Levosimendan as treatment option in severe verapamil intoxication: a case report and review of the literature.’, 2010. Available at: https://doi.org/10.1155/2010/546904.

Bernsmeier C and Heim MH (2009) ‘Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance.’, Swiss medical weekly, 139(47-48), pp. 678–84. Available at: https://doi.org/10.4414/smw.2009.12765.

Bernsmeier C. and Heim M.H. (2009) ‘Insulin resistance in chronic hepatitis C: Mechanisms and clinical relevance’, Swiss Medical Weekly, 139(47-48), pp. 678–684.

Bernsmeier, Christine et al. (2009) ‘NAFLD or NASH - insights from a longitudinal cohort study’. E M H SWISS MEDICAL PUBLISHERS LTD, 139.

Bernsmeier, C. et al. (2009) ‘DYSREGULATION OF GLUCONEOGENESIS IN CHRONIC HEPATITIS C: THE ROLE OF PROTEIN PHOSPHATASE 2A’. ELSEVIER SCIENCE BV, 50.

Heim, M. H. et al. (2009) ‘S-ADENOSYL-METHIONINE (SAME) IMPROVES EARLY VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS WITH PREVIOUS NON-RESPONSE’, JOURNAL OF HEPATOLOGY. WOS.SCI, 50, pp. S226–S226.

Bernsmeier, Christine et al. (2008) ‘Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C’, Journal of hepatology, 49(3), pp. 429–40. Available at: https://doi.org/10.1016/j.jhep.2008.04.007.

Bernsmeier, Christine et al. (2007) ‘PP2A overexpression in chronic hepatitis C inhibits insulin signaling in the liver’. JOHN WILEY & SONS INC, 46.

Christen V et al. (2007) ‘Inhibition of alpha interferon signaling by hepatitis B virus.’, Journal of virology. 25.10.2006, 81(1), pp. 159–65. Available at: https://doi.org/10.1128/jvi.01292-06.

von Wagner,Michael et al. (2005) ‘Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.’, GASTROENTEROLOGY (PRINT-AUSGABE), 129(6), pp. 522–7.

von Wagner, M et al. (2004) ‘Randomized multicenter study comparing 16 vs. 24 weeks of combination therapy with peginterferon alfa-2a plus ribavirin in patients chronically infected with HCV genotype 2 or 3’, HEPATOLOGY. WOS.SCI, 40, pp. 725A–725A.